Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2018-10-16
Received: 19 October 2017
Accepted: 16 September 2018
First Online: 16 October 2018
Ethics approval and consent to participate
: This study was reviewed and received approval from Schulman IRB.
: Not applicable.
: <tt>○</tt> Virginia S. Haynes, Adam S. Fleisher, Michael Witte, AnnCatherine Downing, are full-time employees and stockholders of Eli Lilly and Company.<tt>○</tt> Daniel E. Ball is a stockholder of Eli Lilly and Company.<tt>○</tt> Radhika Nair and Nick Patel are employees of Comprehensive Health Insights, Humana Inc., which received funding and Sponsorship from Eli Lilly and Humana to conduct this study.<tt>○</tt> Vishal Saundankar, Mir Siadaty, and Leslie Hazel-Fernandez, were employees of Comprehensive Health Insights, Humana Inc. at the time of the study.<tt>○</tt> Daniel E. Ball was an employee of Eli Lilly and Company at the time of the study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.